SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318154-21-000045
Filing Date
2021-11-03
Accepted
2021-11-02 20:08:39
Documents
82
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amgn-20210930.htm   iXBRL 10-Q 2615751
2 AGREEMENT AND PLAN OF MERGER WITH TENEOBIO, INC. amgn-ex27_202193021xq3.htm EX-2.7 914076
3 RULE 13A-14(A) CERTIFICATIONS amgn-ex31_2021930xq3.htm EX-31 19971
4 SECTION 1350 CERTIFICATIONS amgn-ex32_2021930xq3.htm EX-32 9634
  Complete submission text file 0000318154-21-000045.txt   11769736

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20210930.xsd EX-101.SCH 63440
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amgn-20210930_cal.xml EX-101.CAL 67092
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20210930_def.xml EX-101.DEF 362987
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20210930_lab.xml EX-101.LAB 716814
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20210930_pre.xml EX-101.PRE 502747
10 EXTRACTED XBRL INSTANCE DOCUMENT amgn-20210930_htm.xml XML 2286246
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37702 | Film No.: 211373225
SIC: 2836 Biological Products, (No Diagnostic Substances)